Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
35.41Prev. Close
37.14Volume
1,035Total traded value
0.00 CrUpper Circuit
38.99Lower Circuit
35.29Fundamentals
| Market Cap | ₹176Cr |
| ROE | 96.45% |
| P/E Ratio(TTM) | 19.97 |
| EPS(TTM) | 1.86 |
| P/B Ratio | 17.63 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | 2.11 |
| Debt to Equity | 3.31 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Kimia Biosciences
Kimia Biosciences is a pharmaceutical company that researches and develops new drugs, with the objective of producing effective, safe, and affordable medicines. The company's core purpose revolves around providing wellness and healthy choices for its consumers, a mission that has remained constant. Its research and development team has grown to over 60 scientists and has successfully commercialized more than 25 products.;
| Parent Organisation | Kimia Biosciences Limited |
| Managing Director | Mr. Sameer Goel |
| BSE Symbol | 530313 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 70.13 | ||
| Neuland Laboratories | NA (0.00%) | 111.47 | ||
| Jubilant Pharmova | NA (0.00%) | 37.80 | ||
| Acutaas Chemicals | NA (0.00%) | 62.78 |